| 英文名称 | 中文名称 | CAS | MF |
|
RneasyFibrousTissueMiniKit(50)
|
|
|
|
|
RneasyProtectMiniKit(250)
|
|
|
|
|
RneasyProtectMaxiKit(12)
|
|
|
|
|
RneasyLipidTissueMiniKit(50)
|
|
|
|
|
RneasyMicroKit(50)
|
RNEASY 迷你试剂盒(50)
|
|
|
|
RneasyProtectBacteriaMidiKit(10)
|
|
|
|
|
RneasyFfpeKit(50)
|
|
|
|
|
RneasyProtectSalivaMiniKit(50)
|
|
|
|
|
Rneasy96Kit(12)
|
|
|
|
|
RneasyProtectMiniKit(50)
|
|
|
|
|
RneasyMiniKit(250)
|
RNEASY迷你试剂盒(250)
|
|
|
|
RneasyMidiKit(50)
|
|
|
|
|
RneasyProtectBacteriaMiniKit(50)
|
|
|
|
|
RneasyPlusMiniKit(50)
|
|
|
|
|
(R)-Modafinil-d10
|
(R)-Modafinil-d10
|
|
C15H17NO2S
|
|
(R)-Modafinil-d10 Carboxylate Methyl Ester
|
|
|
C16H16O3S
|
|
(R)-Modafinil-d10 Carboxylate
|
|
|
C15H14O3S
|
|
Armodafinil
|
阿莫达非尼
|
112111-43-0
|
C15H15NO2S
|
|
(R)-(-)-Modafinil Acid
|
2-[(R)-(二苯基甲基)亚砜]乙酸
|
112111-45-2
|
C15H14O3S
|
|
rNedd4 protein
|
|
|
|
|
RNCX1 exchanger
|
|
|
|
|
(R)-N-(1-cyanocyclopropyl)-4-fluoro-4-Methyl-2-((R)-2,2,2-trifluoro-1-(4'-(Methylsulfonyl)biphenyl-4-yl)ethylaMino)pentanaMide coMpound with (S)-N-(1-cyanocyclopropyl)-4-fluoro-4-Methyl-2-((S)-2,2,2-trifluoro-1-(4'-(Methylsulfonyl)biphenyl-4-yl)ethylaMino
|
|
|
|
|
(R)-N-(5-Cyano-2-nitrobenzyl)-N-(1-hydroxy-3-phenylpropan-2-yl)thiophene-2-sulfonaMide
|
(R)-N-(5-Cyano-2-nitrobenzyl)-N-(1-hydroxy-3-phenylpropan-2-yl)thiophene-2-sulfonaMide
|
530145-62-1
|
C21H19N3O5S2
|
|
(R)-N-cyclopropylpyrrolidin-3-amine
|
(3S)-N-环丙基-3-氨基吡咯烷
|
577776-80-8
|
C7H14N2
|
|
(R)-N-(Cyclohex-3-en-1-yl)acetaMide
|
(R)-N-(环己-3-烯-1-基)乙酰胺
|
196703-47-6
|
C8H13NO
|
|
(R)-N-Cyclopentyl-2-butanamine
|
|
|
C9H19N
|
|
[R,(+)]-N-[2-(Cyclohexylsulfamoyl)ethyl]-2,4-dihydroxy-3,3-dimethylbutyramide
|
|
|
C14H28N2O5S
|
|
[R,(-)]-N-Cyclopropylmethyl-1-methyl-2-phenylethanamine
|
|
|
C13H19N
|
|
(R)-N-(4-Dodecylphenylsulfonyl)pyrrolidine-2-carboxaMide
|
(R)-N-(4-DODECYLPHENYLSULFONYL)PYRROLIDINE-2-CARBOXAMIDE
|
1134192-85-0
|
C23H38N2O3S
|
|
Rnd1 protein
|
|
|
|
|
Lobradimil
|
Lobradimil
|
159768-75-9
|
C49H75N15O12S
|
|
RmpA2 protein
|
|
|
|
|
rnfB protein
|
|
|
|
|
(4R)-MONASTROL
|
(R)-MONASTROL
|
268739-54-4
|
C14H16N2O3S
|
|
rnfC protein
|
|
|
|
|
rmPDGF-BB
|
rmPDGF-BB
|
|
|
|
(1R)-(+)-Neocarvomenthol
|
|
1126-40-5
|
C10H20O
|
|
(R)-MONOPHOS
|
-(-)-(3,5-二氧-4-磷-环庚并[2,1-A:3,4-A']二萘-4基)二甲胺
|
157488-65-8
|
C22H18NO2P
|
|
(R)-MONOPHOS
|
(S)-(+)-(3,5-二氧-4-磷-环庚基[2,1-A,3,4-A']二萘基)二甲胺
|
185449-80-3
|
C22H18NO2P
|
|
R-10-MONOHYDROXY-DIHYDRO-CARBAMAZEPIN
|
(R)-艾司利卡西平
|
104746-03-4
|
C15H14N2O2
|
|
(1R)-(-)-Neoisocarvomenthol
|
|
1126-41-6
|
C10H20O
|
|
(8R)-8α-(β-L-Xylopyranosyloxy)labd-13-en-15-ol
|
|
|
|
|
(8R)-8α-(β-L-Xylopyranosyloxy)labd-13-ene-15,16-diol
|
|
|
|
|
(R)-2-NEOPENTYL-SUCCINIC ACID 1-METHYL ESTER
|
|
|
C10H18O4
|
|
RMOPN
|
|
|
|
|
(R)-N-EPSILON-T-BUTOXYCARBONYL-EPSILON-AMINO-CAPROLACTAM
|
|
|
C11H20N2O3
|
|
RLZF-Y protein
|
|
|
|
|
(R)-(-)-Mosapramine
|
|
120181-35-3
|
C28H35ClN4O
|
|
(R)-Morpholin-3-yl-acetic acid
|
(R)-3-吗啉乙酸
|
1257848-43-3
|
C6H11NO3
|
|
(R)-2-Morpholineacetic acid
|
(R)-2-吗啉乙酸
|
1257854-97-9
|
C6H11NO3
|
|
(R)-4-Morpholino-1-(phenylthio)-2-butylamine
|
(R)-1-(苯硫基)-4-(4-吗啉基)-2-丁胺
|
870812-95-6
|
C14H22N2OS
|
|
4-[[(1R)-3-(4-Morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-trifluoromethylsulfonyl-benzenesulfonamide
|
4-[[(R)-3-(吗啉-4-基)-1-[(苯硫基)甲基]丙基]氨基]-3-三氟甲磺酰基苯磺酰胺
|
1027345-12-5
|
C21H26F3N3O5S3
|
|
4-[[(1R)-3-(4-Morpholinyl)-3-oxo-1-[(phenylthio)methyl]propyl]amino]-3-trifluoromethylsulfonyl-benzenesulfonamide
|
4-[[(1R)-3-(4-吗啉基)-3-氧代-1-[(苯硫基)甲基]丙基]氨基]-3-[(三氟甲基)磺酰基]苯磺酰胺
|
1027345-11-4
|
C21H24F3N3O6S3
|
|
4-[[(1R)-3-(4-Morpholinyl)-3-oxo-1-[(phenylthio)methyl]propyl]amino]-3-trifluoromethylsulfonyl-benzenesulfonamide-d8
|
|
|
C21H24F3N3O6S3
|
|
(2R)-morpholine-2-carboxylic acid
|
(R)-吗啉-2-甲酸
|
1212396-52-5
|
C5H9NO3
|
|
(1R)-3-morpholin-4-yl-1-[(phenylthio)methyl]propylamine
|
|
|
C14H22N2OS
|
|
(R)-Morpholin-3-ylmethanol hydrochloride
|
(R)-3-羟甲基吗啉盐酸盐
|
1212377-10-0
|
C5H12ClNO2
|
|
(R)-1-Morpholinopropan-2-aMine hydrochloride
|
(R)-1-(4-吗啉基)-2-丙胺盐酸盐
|
1161931-61-8
|
C7H17ClN2O
|
|
(R)-2-MorpholineMethanol HCl
|
(R)-2-吗啉甲醇盐酸盐
|
1436436-17-7
|
C5H12ClNO2
|
|
(R)-2-Morpholinecarboxylic acid HCl
|
(R)-2-吗啉羧酸
|
1273577-14-2
|
C5H10ClNO3
|
|
(R)-Morpholine-3-carboxylic acid HCl
|
(R)-3-吗啉基羧酸
|
1187928-88-6
|
C5H10ClNO3
|
|
(R)-1-(3-MORPHOLIN-4-YL-PHENYL)-ETHYLAMINE
|
|
1018688-82-8
|
C12H18N2O
|
|
[R,(-)]-3-(Morpholinocarbonyl)-2-(1-naphtylmethyl)propionic acid
|
|
|
C19H21NO4
|
|
(R)-3-MORPHOLINECARBOXYLIC ACID
|
|
|
C5H9NO3
|
|
(R)-3-Morpholinecarboxylic Acid
|
(R)-3-羧基吗啉
|
106825-81-4
|
C5H9NO3
|
|
(2R)-2-[[[3-(4-MORPHOLINYLMETHYL)-2H-1-BENZOPYRAN-8-YL]OXY]METHYL]MORPHOLINE DIMETHANESULFONATE
|
(2R)-2-[[[3-(4-MORPHOLINYLMETHYL)-2H-1-BENZOPYRAN-8-YL]OXY]METHYL]MORPHOLINE DIMETHANESULFONATE
|
205242-62-2
|
C20H30N2O7S
|
|
((R)-morpholin-2-yl)methanol
|
R-(吗啉-2-基)甲醇
|
156925-22-3
|
C5H11NO2
|
|
4-Boc-3(R)-morpholinecarboxylic acid
|
(3R)-3,4-吗啉二羧酸 4-叔丁酯
|
869681-70-9
|
C10H17NO5
|
|
3(R)-MORPHOLINECARBOXYLIC ACID METHYL ESTER
|
|
|
C6H11NO3
|
|
(R)-3-MORPHOLINO-1-PHENYLPROPAN-1-AMINE
|
|
|
C13H20N2O
|
|
(R)-Morpholine-3,4-dicarboxylic acid 4-tert-butyl
|
|
|
|
|
3(R)-Morpholinecarboxylic acid methyl ester HCl
|
|
|
C6H12ClNO3
|
|
(1R)-1-[4-(MORPHOLIN-4-YLSULFONYL)PHENYL]ETHANOL
|
|
|
C12H17NO4S
|
|
(1R)-1-[4-(MORPHOLIN-4-YLSULFONYL)PHENYL]ETHANAMINE
|
|
|
C12H18N2O3S
|
|
(1R)-1-(2-MORPHOLIN-4-YLPHENYL)PENTYLAMINE
|
|
|
C15H24N2O
|
|
rLysostaphin
|
|
|
|
|
RLYSOZYME
|
|
|
|
|
rLYSOZYME SOLUTION
|
|
|
|
|
rLYSOZYME SOLUTION, VEGGIE GRADE
|
|
|
|
|
(3R)-N-ETHYL-3-PIPERIDINECARBOXAMIDE
|
|
881546-33-4
|
C8H16N2O
|
|
(R)-N-Ethyl AMphetaMine Hydrochloride
|
(R)-N-Ethyl AMphetaMine Hydrochloride
|
26194-85-4
|
C11H18ClN
|
|
(R)-N-Ethyl AMphetaMine-d5 Hydrochloride
|
|
|
C11H18ClN
|
|
(3R)-N-Ethylpiperidin-3-amine dihydrochloride
|
|
|
C7H18Cl2N2
|
|
(R)-N-ethyl-2-(5-((R)-pyrrolidin-3-yl)-1,3,4-oxadiazol-2-yl)pyrrolidine-1-carboxaMide
|
|
|
C13H21N5O2
|
|
(12R)-Lythrancane-8α,9α,12-triol
|
|
32209-71-5
|
C27H35NO5
|
|
[R,(+)]-N-[2-(Ethylphenylsulfamoyl)ethyl]-2,4-dihydroxy-3,3-dimethylbutyramide
|
|
|
C16H26N2O5S
|
|
(1R)-N-Ethyl-1-methyl-2-phenylethanamine
|
|
33817-12-8
|
C11H17N
|
|
(12R)-Lythrancane-8α,12-diol diacetate
|
|
32209-77-1
|
C31H39NO6
|
|
(3R)-N-Ethyl-1-(9H-xanthen-9-yl)-3-pyrrolidinamine
|
|
52963-48-1
|
C19H22N2O
|
|
(1R)-N-(4-Ethoxyphenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|
|
[R,(-)]-N-Ethyl-p-methoxy-α-methylphenethylamine
|
|
|
|
|
(R)-N-(α-Ethyl-α-methylbenzyl)benzamide
|
|
|
|
|
(12R)-Lythrancane-8α,12-diol
|
|
32209-75-9
|
C27H35NO4
|
|
(αR)-N-Ethyl-α-methylbenzenemethanamine
|
|
|
|
|
(1R,1α,4α)-N-Ethyl-3α-phenylbicyclo[2.2.1]heptan-2α-amine
|
|
|
|
|
(12R)-Lythrancane-8α,9α,12-triol 12-acetate
|
|
32209-72-6
|
C29H37NO6
|
|
(1R)-N-(2-Ethylphenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|
|
(1R)-N-(2-Ethoxycarbonylphenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|
|
(12R)-Lythrancane-8α,12-diol 12-acetate
|
|
32209-76-0
|
C29H37NO5
|
|
(1R)-N-(6-Ethyl-2-methylphenyl)-1,2,3,4,4a,5,6,7,8,9,10,10a-dodecahydro-7-isopropyl-1,4a-dimethylphenanthrene-1α-carboxamide
|
|
|
|